Latest debt-to-equity ratio
Arcus Biosciences Debt-to-equity ratio
Direct answer
Arcus Biosciences's debt-to-equity ratio is 51.29%.
The verified market snapshot reports 51.29%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 10, 2026.
Get free Arcus Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 51.29%
Explore related company data
View Arcus Biosciences's market capitalizationView Arcus Biosciences's price-to-book ratioView Arcus Biosciences's return on equityView Arcus Biosciences's dividend yieldView Arcus Biosciences's 52-week price rangeView Arcus Biosciences's revenue growthView Arcus Biosciences's profit marginView all Arcus Biosciences key metricsReturn to Arcus Biosciences profile